Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 21:12:1417499.
doi: 10.3389/fpubh.2024.1417499. eCollection 2024.

Correlation between the APOE ε4 genotype, lifestyle habits, and cognitive deficits in Chinese adults over 60: a cross-sectional analysis in China

Affiliations

Correlation between the APOE ε4 genotype, lifestyle habits, and cognitive deficits in Chinese adults over 60: a cross-sectional analysis in China

Wei Li et al. Front Public Health. .

Abstract

Introduction: Apolipoprotein E (APOE) epsilon 4 is regarded as the most significant genetic contributor linked to mild cognitive impairment (MCI) and Alzheimer's disease (AD). Daily life elements might also influence cognitive abilities to some extent. This research aimed to investigate whether carrying APOE ε4 alters the effects of lifestyle on cognitive ability.

Methods: The research included 1871 senior community members with APOE gene data, all participating in clinical, neuropsychological, and daily living factor assessments. Based on their APOE ε4 status, they were categorized into two groups: the APOE ε4 group (n = 362) and the non-APOE ε4 group (n = 1,509). Subsequently, a multivariate logistic regression analysis was employed to investigate the link between cognitive deficits and APOE ε4, along with lifestyle patterns.

Results: Our research revealed a reduced incidence of MCI (OR = 0.745, 95% CI: 0.587-0.945, p = 0.015) and dementia (OR = 0.422, 95% CI: 0.259-0.688, p = 0.001) in the non-APOE ε4 carriers. Furthermore, the general linear regression analysis revealed a notable interplay between APOE ε4 and sleep disturbances, potentially impacting cognitive deterioration together (F = 6.817, p = 0.001).

Conclusions: The research indicates that possessing APOE ε4 alters the impact of everyday life factors on cognitive decline. In addition, there is a significant interaction between APOE ε4 and sleep disorders, which may jointly lead to the appearance of cognitive impairment.

Keywords: APOE ε4; community; dementia; mild cognitive impairment; ways of living.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Kahya M, Vidoni E, Burns JM, Thompson AN, Meyer K, Siengsukon CF. The relationship between apolipoprotein ε4 carrier status and sleep characteristics in cognitively Normal older adults. J Geriatr Psychiatry Neurol. (2017) 30:273–9. doi: 10.1177/0891988717720301, PMID: - DOI - PMC - PubMed
    1. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, et al. . APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from Central Norway. BMC Neurol. (2008) 8:9. doi: 10.1186/1471-2377-8-9, PMID: - DOI - PMC - PubMed
    1. Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. (2013) 9:106–18. doi: 10.1038/nrneurol.2012.263 - DOI - PMC - PubMed
    1. Valero S, Marquié M, de Rojas I, Espinosa A, Moreno-Grau S, Orellana A, et al. . Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a memory clinic. Sci Rep. (2020) 10:20058. doi: 10.1038/s41598-020-77023-z, PMID: - DOI - PMC - PubMed
    1. Venneri A, McGeown WJ, Biundo R, Mion M, Nichelli P, Shanks MF. The neuroanatomical substrate of lexical-semantic decline in MCI APOE ε4 carriers and non-carriers. Alzheimer Dis Assoc Disord. (2011) 25:230–41. doi: 10.1097/WAD.0b013e318206f88c, PMID: - DOI - PubMed

Substances

LinkOut - more resources